Showing results (1-10 of 166) with videos related to
Sort By:
Pageof 17
Current Opinion in Nephrology and Hypertension|October 23, 2008
Altered nonrenal drug clearance in ESRDThomas D NolinSeminars in Dialysis|April 10, 2015
A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKDThomas D NolinThe Journal of Pharmacology and Experimental Therapeutics|August 11, 2019
Simultaneous Assessment of Hepatic Transport and Metabolism Pathways with a Single Probe Using Individualized PBPK Modeling of <sup>14</sup>CO<sub>2</sub> Production Rate DataYoko Franchetti, Thomas D NolinJournal of Clinical Pharmacology|January 18, 2021
Application of Individualized PBPK Modeling of Rate Data to Evaluate the Effect of Hemodialysis on Nonrenal Clearance PathwaysYoko Franchetti, Thomas D NolinHandbook of Experimental Pharmacology|December 19, 2009
Mechanisms of drug-induced nephrotoxicityThomas D Nolin, Jonathan HimmelfarbJournal of Clinical Pharmacology|November 18, 2020
Dose Optimization in Kidney Disease: Opportunities for PBPK Modeling and SimulationYoko Franchetti, Thomas D NolinExpert Review of Clinical Pharmacology|September 15, 2017
Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney diseaseAlexander J Prokopienko, Thomas D NolinExpert Review of Clinical Pharmacology|May 31, 2014
Kidney function assessment and its role in drug development, review and utilizationMichael A Tortorici, Thomas D NolinCurrent Drug Metabolism|June 6, 2016
Implications of Kidney Disease on Metabolic ReductionOsama Y Alshogran, Thomas D NolinAdvances in Chronic Kidney Disease|March 4, 2018
Pragmatic Use of Kidney Function Estimates for Drug Dosing: The Tide Is TurningJoanna Q Hudson, Thomas D NolinPageof 17